Michael Vangrouw, PA
Physician Assistant · Newville, PANPI 1417925413
Payments from drug & device makers
Across 124 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$247
- AbbVie$237
- GSK$196
- AstraZeneca$196
- Boehringer Ingelheim$179
- Pfizer$129
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $247 |
| AbbVie | 10 | $237 |
| GSK | 10 | $196 |
| AstraZeneca | 12 | $196 |
| Boehringer Ingelheim | 11 | $179 |
| Pfizer | 7 | $129 |
| Merck | 6 | $118 |
| Sanofi Pasteur Inc. | 4 | $98 |
| Lilly USA, LLC | 6 | $97 |
| Amgen | 6 | $93 |
| Exact Sciences | 4 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $63 |
| Novartis | 3 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| Abbott | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $39 |
| Johnson & Johnson | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
| IBSA Pharma Inc. | 1 | $22 |
| Indivior Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Cequr Corporation | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$2,329 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 92 | $77,735 |
| TrulicityDulaglutide | 60 | $75,337 |
| OzempicSemaglutide | 58 | $56,388 |
| EliquisApixaban | 31 | $35,843 |
| MounjaroTirzepatide | 38 | $34,648 |
| ProliaDenosumab | 20 | $33,364 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $20,540 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $16,830 |
| XareltoRivaroxaban | 21 | $14,302 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $11,888 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $11,731 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $11,200 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $8,036 |
| Atorvastatin Calcium | 440 | $6,881 |
| Repatha SureclickEvolocumab | 11 | $6,026 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $97 | $109,98498 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $179 | $89,623112 claims |
| Novo NordiskOzempic | $247 | $56,38858 claims |
| PfizerEliquis | $129 | $35,84331 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Shingrix | $196 | $35,35164 claims |
| AmgenProlia | $93 | $33,36420 claims |
| Johnson & JohnsonXarelto | $36 | $14,30221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Newville
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.